Davies SJC, Westin AA, castberg I, Lewis G, Lennard MS, Taylor S, Spigset O. Characterisation of zuclopenthixol metabolism by in vitro and therapeutic drug monitoring studies. Acta Psychiatr Scand 2010; 122: 444-53
Link
Molden E, Spigset O. Tobakksrøyking og interaksjoner med legemidler. Tidsskr Nor Legeforen 2009; 129: 632-3.
Link
Spigset O, Molden E. Cytokrom P-450 3A4 – kroppens viktigste arena for legemiddelinteraksjoner. Tidsskr Nor Legeforen 2008; 128: 2832-5.
Link
Molden E, Spigset O. Frukt og bær - interaksjoner med legemidler. (Fruit and berries – interactions with drugs). Tidsskr Nor Lægeforen 2007; 127: 3218-20.
Link
Castberg I, Spigset O. Effects of comedication on the serum levels of aripiprazole: evidence form a routine therapeutic drug monitoring service. Pharmacopsychiatry 2007; 40: 107-10.
Link
Helland A, Spigset O. Low serum concentrations of reboxetine in 2 patients treated with CYP3A4 inducers. J Clin Psychopharmacol 2007; 27: 308-10.
Link
Castberg I, Skogvoll E, Spigset O. Quetiapine and drug interactions: evidence form a therapeutic drug monitoring service. J Clin Psychiatry 2007; 68: 1540-5.
Link
Jönsson AK, Spigset O, Jacobsson I, Hägg S. Cerebral haermorrhage induced by warfarin – the influence of drug-drug interactions. Pharmacoepid Drug Saf 2007; 16: 309-15.
Link
Castberg I, Spigset O. Risperidone and lamotrigine: no evidence of a drug interaction. J Clin Psychiatry 2006; 67: 1159.
Link
Spigset O. Legemiddelinteraksjoner og databaser. Tidsskr Nor Lægeforen 2005; 125: 330.
Link
Castberg I, Berle JØ, Spigset O. Kombinasjonsbehandling med karbanazepin og quetiapin. Tidsskr Nor Lægeforen 2005; 17: 2397-8.
Link (PDF-dokument)